As opioid deaths surge across Australia, pharmacists still choose to not stock naloxone

Since 2022, the federal government has invested $26.1 million to help make naloxone, a medicine that blocks the effects of opioids, widespread. Yet some pharmacists are still choosing to not stock the medicine. Since 2022, the federal government has invested $26.1 million to help make naloxone, a medicine that blocks the effects of opioids, widespread. Yet some pharmacists are still choosing to not stock the medicine. Drugs, Pharmaceutical Industry, Pharmaceuticals, Healthcare and Community Services Industry, Death and Dying Latest business news